Peter Evan Harwin's Net Worth
$47.6 Million
Who is Peter Evan Harwin?
Peter Evan Harwin has an estimated net worth of $47.6 Million. This is based on reported shares across multiple companies, which include Apogee Therapeutics, Inc., Mirati Therapeutics, Inc., Viridian Therapeutics, Inc.\DE, Cogent Biosciences, Inc., Spyre Therapeutics, Inc., and Dianthus Therapeutics, Inc. /DE/.
SEC CIK
Peter Evan Harwin's CIK is 0001663607
Past Insider Trading and Trends
2023 was Peter Evan Harwin's most active year for acquiring shares with 10 total transactions. Peter Evan Harwin's most active month to acquire stocks was the month of August. 2023 was Peter Evan Harwin's most active year for disposing of shares, totalling 1 transactions. Peter Evan Harwin's most active month to dispose stocks was the month of December. 2023 saw Peter Evan Harwin paying a total of $11,398,631.97 for 3,624,271 shares, this is the most they've acquired in one year. In 2024 Peter Evan Harwin cashed out on 892,529 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Apogee Therapeutics, Inc. (APGE) Snapshot price: $36.79
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
| 2.05M |
Mar 28
| |||
Form 4
| -88.53% | -790.20K |
—
|
—
| 102.33K |
Scheduled
|
Jan 29
| ||
Form 4
|
∞
| 2.94M |
$17.00 | $49,999,992.00 | 2.94M |
Jul 13
| |||
No matching records found |
Mirati Therapeutics, Inc. (MRTX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Viridian Therapeutics, Inc.\DE (VRDN) Snapshot price: $17.73
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Cogent Biosciences, Inc. (COGT) Snapshot price: $5.865
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Spyre Therapeutics, Inc. (AGLE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +961.81% | 3.64M |
—
|
—
| 4.02M |
Apr 25
| |||
Form 4
| -76.36% | -2.62M |
—
|
—
| 812.08K |
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
|
∞
| 3.44M |
—
|
—
| 3.44M |
Nov 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |